PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.06
0.06 - 0.24
2.78M / 3.59M (Avg.)
-1.55 | -0.04
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
0.15
Positive P/E while CRN.AX shows losses. John Neff would investigate competitive advantages.
4.22
P/S above 1.5x CRN.AX's 1.51. Michael Burry would check for mean reversion risks.
-0.60
Negative equity while CRN.AX shows P/B of 0.74. Joel Greenblatt would examine balance sheet repair potential.
-1.55
Negative FCF while CRN.AX shows P/FCF of 50.98. Joel Greenblatt would examine cash flow improvement potential.
-0.99
Negative operating cash flow while CRN.AX shows P/OCF of 12.69. Joel Greenblatt would examine operational improvement potential.
-0.60
Negative fair value while CRN.AX shows ratio of 0.74. Joel Greenblatt would examine valuation model differences.
169.45%
Positive earnings while CRN.AX shows losses. John Neff would investigate earnings advantage.
-64.42%
Negative FCF while CRN.AX shows yield of 1.96%. Joel Greenblatt would examine cash flow improvement potential.